Introduction
Despite the wide availability of clinically useful antifungal drugs such as imidazole compounds and distinct antibiotics, there is still a current need for effective novel antifungal agents without adverse effects. The dramatic increase in fungal infections is reportedly related to the growing number of im munocompromised patients associated with a great morbidity (Walsh, 1992; Coleman et al., 1998) .
In the search of the underlying active prin ciple^) of medicinally used Pelargonium species of therapeutic potential for the treatment of infec tions of the respiratory tract, we have recently evaluated the antibacterial activity of Pelargonium constituents (Kayser and Kolodziej, 1997) , fol lowed by a systematic study on the antimicrobial activities of tannins (Kolodziej et al., 1999) . A l though tannins are generally recognized as re markable antimicrobials, our results clearly de monstrated that the potential of chemically defined polyphenols to inhibit the growth of bac teria is less prominent than commonly anticipated, but they also revealed fairly high anticryptococcal properties of hydrolysable tannins. This finding prompted the present investigation to ascertain whether members of this group of phenolic metab olites tend to be broadly potent or very specific fungitoxic agents. It should be noted that antifun gal properties of tannins are well documented, but also that some fungi are known to utilize tannins as a unique source of carbon for growth (Scalbert, 1991) . However, limited data exist on the suscep tibility of the type of fungus to the toxic effects of chemically defined hydrolysable tannins, structure-activity relationships and dependence of anti fungal effects on test methods (Paxton, 1991) . In this study a panel of human pathogenic fila mentous fungi and yeasts was tested for suscep tibility to a series of hydrolysable tannins and re lated compounds of high purity.
Test compounds
Compounds examined in this report were iso lated from Pelargonium reniforme ssp. reniforme (Latte, 1999) . The purity and identity of the sam ples were proven by chromatographic and spectro scopic techniques. Amphotericin B was from Fluka, Germany, and sertaconazole (Zalain®) was a generous gift of Trommsdorff GmbH & Co, Aachen, Germany.
Microorganisms
The following microorganisms used for the anti fungal evaluation are either clinical isolates and were kindly provided by Dr. 
Antifungal assays
The fungitoxic activity of the samples was eval uated with the agar dilution method by using RPMI 1640 medium supplemented with 2% glu cose containing 0.75% agar for both filamentous fungi and yeasts. The assay was carried out in 12-well microtiter plates. Stock solutions of test sam ples (2% ) in the RPM I 1640 medium were diluted to give serial two-fold dilutions. Using a micropi pet, an inoculum of 0.5 jil of the yeast cell suspen sions (102 colony forming units/|.d) was added to each well. For the filamentous fungi, mycelial inMaterials and Methods ocula were transferred to the agar wells. The anti fungal agents amphotericin B and sertaconazole were included in the assay as positive controls. The final concentration of DMSO, used as solvent for the reference compounds, did not exceed 1% (Sei bold and Werner, 1995) and did not affect the growth of any of the microorganisms. The plates were incubated 24 h at 37 °C (yeasts) up to 8 days at 26 °C for dermatophyte strains. Minimum inhib itory concentration (M IC) of the samples was de fined as the lowest compound concentration show ing no fungal growth after incubation time as determined by direct visual and/or turbidimetric comparison of the test culture with a control (Van Cutsem et al., 1994) .
In an independent experiment, samples were subjected to the broth microdilution method for antifungal activity using the liquid RPM I 1640 me dium. The protocol of this assay was identical to the semisolid agar dilution method (vide supra).
Fungicidal kinetic assay
The fungicidal kinetic assay for C. albicans ATCC 90028 was performed in RPM I 1640 me dium with 2% glucose containing gallic acid (1) in concentrations of 1.5 to 11.8 ^im (25 0 -2 0 0 0 |ig/ml). The averaged initial inoculum was 54 colony-form ing units. Samples were taken after 1 and 5 h of incubations, followed by plating on Sabouraud agar. After 48 h of incubation at 35 °C, growth of the fungus was determined by microscopic analy sis.
Results and Discussion
Although tannins are known to possess antifun gal activity (Scalbert, 1991) , the effect of tannin structure on the potency has not been investigated systematically. Following our recent finding that tannin concentration and composition apparently define appreciable toxicity for bacteria in most cases (Kolodziej et al., 1999) , a similar more sys tematic investigation of the antifungal activities of hydrolysable tannins will provide information on the susceptibility of human pathogenic and oppor tunistic fungi to representatives of this class of tannins and will establish whether the antifungal activity can be ascribed to qualitative or quantita tive parameters.
Following various modifications of the RMPI 1640 broth in preliminary tests, addition of 2% glucose (Espinel-Ingroff et ah, 1998) to the me dium showed excellent growth of the microor ganisms under study, while 0.75% agar estab lished satisfactory semisolid medium conditions. Commonly used Casiton medium proved less suitable due to the presence of ferrum ions in significant amount giving rise to polyphenol complexation.
The antifungal spectrum and the minimum in hibitory concentrations (MICs) of the phenolic samples are displayed in Table I Thus, this finding is highly reminiscent of that of the antibacterial activity of tannins, where pol yphenol concentration and composition proved to be crucial parameters. In contrast, different results were obtained for hydrolysable tannins of the series against yeasts, with some compounds dis playing strong activities.
A s can be seen (Table I) 
E. flocc. M. canis M. gyps. T. ment. T, rnhr. T. tons. P. ital A. fum .
jMethyl ester (2) plucogallin (3) Corilagin ( >11.8 >11.8 (>2000) (>2000) (>2000) >10.9 >10.9 >10.9 (>2000) (>2000) (>2000) >6.0 >6.0 >6,0 (>2000) (>2000) (>2000) >3. As regards structure-activity relationships, it would appear that the presence of pyrogallol ele ments seems to be crucial to produce the biologi cal response against C. glabrata and C. krusei. Both the number of hydroxyl groups and the mo lecular size are apparently no major contributing factors towards antifungal activity. With the excep tion of gallic acid (1) in a single case, compounds 1 -6 display close MIC values of 0 .0 3 -0 .2 | i m (31.2 |ig/ml) and 0 .1 -0 .7 (i m (125 |ig/ml) against C. glabrata and C. krusei, respectively (Table I) .
Cryptococcus neoformans preferentially causes infections in individuals suffering from defective T-cell function such as A ID S patients (Levitz, 1991) . Compounds 1 -6 inhibited this opportunis tic pathogen with MICs ranging from 0.02 to 0.2 | i m (1 6 -3 1 [xg/ml). Similarly, the prominent anticryptococcal potency of the phenolic samples ap pears strongly associated with the presence of galloyl groups in these molecules, while introduction of additional galloyl groups does not necessarily enhance this particular biological activity, as con cluded from preliminary experiments (Kolodziej et al., 1999) . Also, the analysis of active ellagitannin structures reveals that the presence of a hexahydroxydiphenoyl moiety or its oxidatively modified entities may be an important structural feature leading to highly potent anticryptococcal candi dates such as corilagin (4), pelargoniin B (5) and phyllanthusiin C (6) ( Table I) .
With MICs ranging from 0.02 to 0.7 |im ( 1 6 -125 (tg/ml), the potentially active compounds ex amined were generally only moderately fungitoxic, when compared with the MICs 0.0003-0.008 | i m (0 .3 -4 ^ig/ml) of the clinically used agents ampho tericin B and sertaconazole. Despite the consider able difference in antifungal effectiveness, lack of toxicity in these concentration ranges and the less side-effect potential of the hydrolysable tannins tested should be meaningful advantages in their possible employment as fungitoxic agents in man, provided bioavailability.
In an additional set of experiments, the antifun gal activity of gallic acid (1) and corilagin (4) was tested against C. albicans and C. glabrata strains (Table II) using the broth microdilution method to evaluate the antifungal response in dependence on the test method. Selection of C. albicans was sim- (4) ply for convenience, while (1) represents an essen tial unit of hydrolysable tannins. This comparative study was prompted by differences in MIC values observed during our screenings. As can be seen (Tables I and II To test the actual role of galloyl structures in the antifungal activities of natural analogs, vitexin (7), isovitexin (11), orientin (9), isoorientin (13) and their 2"-0-galloylated derivatives 8, 10,12, and 14 were evaluated with the microdilution method. Results indicated that these flavonoids were com pletely devoid of activity in concentrations ranging from 1.7 to 2.3 |im (MICs >1000|ig/ml) against Candida albicans and Cryptococcus neoformans (data not shown). Although gallic acid (1) itself displayed appreciable antifungal activity (Tables I  and II) , this finding clearly demonstrated that the presence of pyrogallol elements per se is not enough to produce antifungal activity for any structural analog. With reference to the active ellagitannins, the failure of the detection of gallic acid excluded their hydrolsis.
The fungicidal kinetic assay, using Candida albi cans and gallic acid (1), demonstrated the antifun gal activity of the test compound to be fungicide, the minimum fungicidal concentration being 5.9 [j,m (1000 ^g/ml) after a 5 h incubation. These data indicate that hydrolysable tannins might be considered a potential source of promis ing antifungal agents for treatment of intestinal in fections caused by opportunistic yeasts. Also, one might speculate that dietary intake of such pol yphenols reduces the risk of some forms of candidosis and related intestinal infections.
